A Study to evaluate if the 3 dose extended schedule (0-6-18 months) for the HPV vaccine Gardasil-9 provide similar immune responses and short term protection against HPV infection compared to the regular 3 dose schedule (0-2-6 months) in high risk women in Vietnam
Is between the reporting ages of 18-26 years at the time of recruitment.
Engage in commercial sex in the last 6m (for FSW group) or have engaged in sexual activity (non-FSWs)
Willing and able to give written informed consent.
Willing to complete the follow-up requirements of the study.
Pregnant or possibly pregnant
Has received any HPV vaccine previously
Has an axillary temperate greater than 38°C
Known allergies to any vaccine component
National Institute of Hygiene and Epidemiology, Vietnam
Lead sponsor
Murdoch Childrens Research Institute
Collaborator
CENTER FOR SUPPORTING COMMUNITY DEVELOPMENT INITIATIVES
Collaborator
Hai Phong Center for Disease Control
Collaborator